Heart Disease Trial, Recruiting NCT06880575 Sponsor: Beijing Hospital Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT06880575
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 75 years of age or older.
  • People who were admitted to hospital due to chest pain (angina) or other symptoms related to coronary heart disease.
  • People who have been diagnosed with coronary heart disease, confirmed by at least one of the following: a coronary angiogram or CT scan of the heart arteries done during this hospital stay; a previous coronary angiogram or CT scan showing coronary heart disease; or a diagnosis made by the treating doctor based on symptoms, medical history, heart tests, or other relevant investigations.
  • People who are able to understand what the study involves, are willing to take part, and are able to sign a consent form.

Who may not be able to join:

  • People who have a serious non-heart-related illness where life expectancy is not expected to exceed 6 months, such as advanced cancer or another end-stage condition.
  • People who are unlikely to be able to participate in long-term follow-up appointments, such as those with severe memory or thinking problems, or a severe mental illness.
  • People who passed away from a non-heart-related cause within 24 hours of being admitted to hospital.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Beijing Hospital
Registry
ClinicalTrials.gov
Start date
6 November 2024
Est. completion
30 June 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

major adverse cardiovascular events

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov